Health Care Checkup

May 16, 2025

THE BIG PICTURE: KEY CONGRESSIONAL & EXECUTIVE BRANCH DEVELOPMENTS


On Wednesday, after a 26-hour markup, the House Energy and Commerce Committee (E&C) advanced its portion of the budget reconciliation package in a 30–24 vote along party lines. Also on Wednesday, the House Ways and Means Committee advanced its portion of the reconciliation bill, focusing on tax provisions, in a 26-19, party-line vote.


On Thursday, the Senate Finance Committee advanced the nominations of James O'Neill to serve as Deputy Secretary of Health and Human Services (HHS) in a 14-13 vote along party lines and Gary Andres to serve as HHS Assistant Secretary in a 19-8 vote.


On Monday, President Trump signed an executive order (EO) that seeks to bring the price of drugs in the U.S. in line with what other countries pay. The policy, known as the most-favored-nation status, is intended to drive drug companies to lower prices domestically.


On Monday, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would end some states’ ability to broadly tax privately run Medicaid managed-care plans. The proposed rule would prohibit states from taxing Medicaid business at higher rates than non-Medicaid business.


On Thursday, the Health and Human Services, Labor, and Treasury departments released a temporary non-enforcement policy of the mental health parity rule that would apply to alleged compliance violations until a related lawsuit brought by the ERISA Industry Committee is resolved, and an additional 18 months after that date.

What to Expect Next Week:


The House Budget Committee failed to pass the reconciliation bill out of Committee on Friday in a 16-21 vote. The Committee will reconvene once a deal is reached with the no votes to reconsider the bill.


The House Oversight and Government Reform Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs will hold a hearing on Tuesday to discuss the Inflation Reduction Act’s impact on energy and healthcare.


In the Senate, the Appropriations Committee will hold a budget hearing on Tuesday on the proposed FY 2026 budget for the Department of Health and Human Services, with HHS Secretary Robert F. Kennedy Jr. testifying. On Thursday, the committee will hold a hearing to consider the proposed FY 2026 budget for the Food and Drug Administration.

DEEP DIVE

Congressional:


House Energy & Commerce and Ways & Means Committee Advance Major Health Care Reconciliation and Tax Bills

On Wednesday, after a 26-hour markup, the House Energy and Commerce Committee (E&C) advanced its portion of the budget reconciliation package in a 30–24 vote along party lines. During the markup, 247 health care amendments were introduced by members, most of which were proposed by Democrats, aiming to remove or change the Medicaid provisions; however, the amendments were ultimately rejected. The committee only adopted one amendment, a substitute amendment (AINS) from Chair Brett Guthrie (R-KY).


The E&C bill would make significant changes to Medicaid, reducing spending by at least $625 billion over ten years, according to preliminary scores by the Congressional Budget Office. The bill proposes, starting in 2029, to require able-bodied Medicaid beneficiaries without dependents, ages 19 to 64, to work at least 80 hours a month. Other proposals in the bill would require states to assess eligibility for the Medicaid expansion population more frequently than current law, requiring eligibility determinations every six months instead of annually, and would eliminate income-based special enrollment periods for the Affordable Care Act exchanges. Chair Guthrie and committee Republicans stated that the provisions are fiscally responsible and politically popular, and that they have learned from states’ rocky implementation of work requirements when crafting the legislation. According to partial estimates from the CBO released by committee Republicans, the committee’s health title would result in a 7.6 million increase in the uninsured.


Also on Wednesday, the House Ways and Means Committee advanced its portion of the reconciliation bill, focusing on tax provisions, in a 26-19, party-line vote. The bill would make permanent the 2017 Trump tax cuts, remove federal taxes on tips and overtime pay, expand and make permanent the 199A small business deduction to 23%, and renew immediate expensing and incentives for research & development in the U.S. The bill would also increase the Child Tax Credit by $500 and establish new savings accounts for newborns, among other provisions. The package is projected to cost $3.8 trillion according to CBO estimates. The bill includes several policies that would expand and enhance Health Savings Accounts and Individual Coverage Health Reimbursement Arrangements. In addition, the bill includes policies that tighten eligibility verification requirements for the ACA’s premium tax credit and limit the PTC’s eligibility for certain populations. During the markup, Democrats offered several amendments to preserve green energy incentives from the Inflation Reduction Act and credits to expand health care coverage under the Affordable Care Act, all of which failed.


The House Budget Committee met on Friday morning to set the rules for considering the reconciliation package, but the bill failed to pass on a 16–21 vote. House Republican leadership will now continue to negotiate with Republican holdouts behind closed doors over the weekend to address their concerns with the legislation, and the Budget Committee will reconvene once a deal is reached with the no votes. If/when the reconciliation legislation passes the Budget Committee, it would then go to the House Rules Committee before being considered on the floor.


Senate Finance Committee Advances HHS Deputy Secretary, Assistant Secretary Picks

On Thursday, the Senate Finance Committee advanced President Trump's picks for Health and Human Services (HHS) Deputy Secretary and Assistant Secretary. The committee voted 14-13 along party lines to advance the nomination of James O'Neill to serve as Deputy Secretary. In his opening statement, Chair Mike Crapo (R-ID) welcomed O'Neill's nomination, highlighting his previous experience in senior roles at HHS under the George W. Bush administration. The committee also voted 19-8 to advance the nomination of Gary Andres to serve as Assistant Secretary of HHS. Andres, a longtime Hill staffer who has served as staff director of the House Budget Committee since 2023, received some Democratic support with Senators Mark Warner (D-VA), Sheldon Whitehouse (D-RI), Maggie Hassan (D-NH), Raphael Warnock (D-GA), and Peter Welch (D-VT) voting in favor of Andres.


Senate HELP and House Appropriations Committee Hold Hearings on HHS Proposed Budget with Secretary Kennedy

On Wednesday, the Senate Health, Education, Labor and Pensions (HELP) Committee and the House Appropriations Labor-HHS-Education Subcommittee held hearings examining the Trump administration's $94 billion budget request for the Department of Health and Human Services (HHS) for fiscal year 2026, with HHS Secretary Robert F. Kennedy Jr. testifying for the first time since he was confirmed as Secretary in February. During the hearings, Kennedy defended the presidential budget request, which would reduce HHS spending by $30 billion, as well as the government's response to a measles outbreak and proposed changes to biomedical research. In the Senate HELP hearing, Kennedy stated that the cuts would right-size agencies that grew too rapidly under President Biden and were not doing enough to improve Americans’ health. Democrats questioned Kennedy on policies and statements he had made that they argued undermined Americans’ confidence in the safety and effectiveness of vaccines. Some committee Republicans also asked questions about cuts and layoffs at HHS, driven by Trump’s Department of Government Efficiency (DOGE) initiative. Chair Bill Cassidy (R-LA) suggested he was concerned about cuts to long COVID research and the National Institutes of Health (NIH).


At the Appropriations hearing, Kennedy agreed to spend the money that Congress allocates for HHS. However, he also defended the proposed cuts, portraying them as a streamlining of a department that has become bloated and inefficient. Ranking Member Rosa DeLauro (D-CT) asked Kennedy for a list of which programs have been eliminated under the reorganization, why they were chosen, and what the criteria were. Kennedy stated that "As of four o'clock yesterday afternoon, we are under a court order not to do any further planning on the reorganization, and I've been advised by my attorneys not to talk about it." He added that some programs under the Centers for Disease Control and Prevention (CDC) had been transferred to the newly formed Administration for a Healthy America.


Senate Judiciary Committee Holds Hearing on Pharmacy Benefit Managers

On Tuesday, the Senate Finance Committee held a hearing examining pharmacy benefit managers (PBMs) and competition in the pharmaceutical supply chain. During the hearing, there was bipartisan agreement that PBM practices lack transparency, which members said has led to the closure of independent pharmacies, particularly in rural areas. Members were also critical of rebate and pricing systems used by PBMs, calling for reforms to require PBMs to disclose fees, pass through savings, and operate with fiduciary responsibility to employers and patients. Additionally, there was broad bipartisan support for the need for legislative and regulatory action, including enhanced Federal Trade Commission (FTC) enforcement, limits on vertical integration, and systemic reforms to restore competition and prioritize patient care. Read Mehlman’s hearing summary here. 


Notable Bills Introduced:


Senators Hawley, Shaheen Introduce Legislation to End Taxpayer-Funded Pharma Ads

On Thursday, Senators Josh Hawley (R-Mo.) and Jeanne Shaheen (D-N.H.) introduced the No Handouts for Drug Advertisements Act, which would end federal tax breaks for pharmaceutical company advertising. The legislation would amend the Internal Revenue Code to disallow tax deductions for expenses related to direct-to-consumer advertising of both prescription drugs and compounded medications. The bill would also define “direct-to-consumer advertising” as advertisements primarily targeted to the general public through television, radio, direct mail, billboards, internet, social media, and other digital platforms. Read the press release here and the bill here.

 

Senator Marshall & Colleagues Introduce Legislation to Reinstate Fairness and Due Process in Health Care

On Thursday, Senators Roger Marshall, M.D. (R-KS) and Elizabeth Warren (D-MA), and Representatives Raul Ruiz, M.D. (D-CA) and John Joyce, M.D. (R-PA), introduced the Physician and Patient Safety Act, legislation that would restore due process rights for physicians. Read the press release here and the bill here.

 

Senators Barrasso, Coons Introduce Bipartisan Expanding Seniors Access to Mental Health Services Act

On Thursday, Senators John Barrasso (R-WY) and Chris Coons (D-DE) introduced the Expanding Seniors Access to Mental Health Services Act. The bill would improve Medicare beneficiaries' access to licensed clinical social workers by providing mental health professionals the opportunity to participate in the Medicare program. Read the press release here and the bill here.

 

Senators Cassidy, Blumenthal Introduce Bill to Lower Costs for Medicare Beneficiaries

On Thursday, Senators Bill Cassidy, M.D. (R-LA) and Richard Blumenthal (D-CT) introduced the Medicare Beneficiary Co-Pay Fairness Act of 2025 to make Medicare’s co-pay structure more affordable by extending the existing co-pay cap to Ambulatory Surgery Centers (ASCs), ensuring fairer costs for patients, and supporting the continued growth and utilization of efficient, lower-cost surgical settings. Read the press release here and the bill here.

 

Senators Capito, Shaheen Reintroduce Access to Prescription Digital Therapeutics Act

On Wednesday, Senators Shelley Moore Capito (R-WV) and Jeanne Shaheen (D-NH) reintroduced bipartisan legislation that would increase access to Prescription Digital Therapeutics (PDTs). The Access to Prescription Digital Therapeutics Act would expand Medicare coverage to include PDTs, which are software-based disease treatments designed to directly treat disease. Read the press release here and the bill here.


Senators Merkley, Welch, Sanders, and Representative Dingell Introduce Bill to Lower Prescription Drug Prices

On Wednesday, Senators Jeff Merkley (D-OR), Peter Welch (D-VT), and Ranking Member of the Senate Health, Education, Labor, and Pensions (HELP) Committee Bernie Sanders (I-VT), along with Representative Debbie Dingell (D-MI), introduced the End Price Gouging for Medications Act. The bill aims to lower prescription drug costs through requiring drug companies to offer medications in the United States at no more than the lowest price per drug in twelve other similarly developed countries: Australia, Austria, Belgium, Canada, France, Germany, Italy, Japan, the Netherlands, Sweden, Switzerland, and the United Kingdom. Read the press release here and the bill here.


Senators Young, Padilla Introduce Bill to Improve Access to Innovative Medical Technologies

On Tuesday, Senators Todd Young (R-IN) and Alex Padilla (D-CA) introduced the Ensuring Patient Access to Critical Breakthrough Products Act. The bill would provide temporary Medicare coverage for medical devices and diagnostic tests approved or cleared under the FDA Breakthrough Devices Program and allow technology developers to work with CMS during the temporary coverage period on a proposal for permanent Medicare coverage. The legislation would also grant CMS permission to immediately suspend or terminate Medicare coverage if subsequent clinical evidence demonstrates that the technology causes harm or provides no clinical benefit to Medicare beneficiaries. Read the press release here and the bill here. 


Executive Branch:


President Trump Signs Most-Favored-Nation Prescription Drug Pricing Executive Order

On Monday, President Trump signed an executive order (EO) that seeks to bring the price of drugs in the U.S. in line with what other countries pay. The policy, known as the most-favored-nation status, is intended to drive drug companies to lower prices domestically. White House officials said Monday this policy seeks to make the global pharmaceutical market more competitive and encourage other countries to contribute to the cost of drug innovation. Trump attempted to implement the policy within Medicare Part B during his first term, but the plan was ultimately blocked during the Biden administration. The EO builds on actions from President Trump’s first term, expanding it to include Medicaid in addition to Medicare. At a press conference Monday morning, Trump stated, "Starting today, the United States will no longer subsidize the health care of foreign countries, which is what we were doing." Read the EO here and the fact sheet here.


CMS Announces Proposed Rule to Close Medicaid Tax Loophole

On Monday, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would end some states’ ability to broadly tax privately run Medicaid managed-care plans. CMS Administrator Mehmet Oz said in a statement that “States are gaming the system — creating complex tax schemes that shift their responsibility to invest in Medicaid and rob federal taxpayers.” The proposed rule would prohibit states from taxing Medicaid business at higher rates than non-Medicaid business; bar the use of vague language to disguise Medicaid-specific taxes; maintain statistical testing while adding safeguards to prevent system gaming; and provide a transition timeline based on the age of existing waivers. Public comments on the rule will be open until July 14, 2025. Read the press release here and the fact sheet here.


Trump Administration Halts Enforcement of Biden’s Mental Health Parity Rule

On Thursday, the Health and Human Services, Labor, and Treasury departments released a temporary non-enforcement policy of the mental health parity rule that would apply to alleged compliance violations until a related lawsuit brought by the ERISA Industry Committee is resolved, and an additional 18 months after that date. Former President Biden’s mental health parity rule created a test for employers to ensure their plans cover mental health care equally with traditional medical services. The rule began taking effect in 2025 but was challenged by the employer advocacy group ERIC in January. The case was put on hold on May 12 after the Trump administration said it was revisiting the rule. The agencies wrote in the press release that “MHPAEA provides critical protections for workers, individuals, and their families who need treatment for mental health conditions and substance use disorders.” “During this period of nonenforcement as the Departments revisit the 2024 Final Rule, the Departments remain committed to ensuring that individuals receive protections under the law in a way that is not unduly burdensome for plans and issuers.” Read the press release here.


CMS Announces Innovation Center Strategy to Make America Healthy Again

On Tuesday, the Centers for Medicare and Medicaid Services’ Innovation Center (CMMI) unveiled a new strategic direction focused on empowering people to achieve their personal health goals. Future model features will include an increase in beneficiary access to information and tools, including mobile-device applications, for disease management and healthy living; published data about providers and services, including cost and quality performance, to support beneficiary decision making; and waivers to support predictable cost-sharing for certain services, drugs, or devices. CMMI Director Abe Sutton said in a Tuesday web briefing that the innovation center strategy change will focus future payment models on three core pillars: promoting evidence-based prevention, empowering people to achieve their health goals, and driving choice and competition. The rollout also aligns with HHS Secretary Robert F. Kennedy Jr.’s agenda to “Make America Healthy Again.” Read the CMMI white paper here.


CMS Seeks Public Input on Improving Technology to Empower Medicare Beneficiaries

On Tuesday, the Centers for Medicare & Medicaid Services (CMS), in partnership with the Office of the National Coordinator for Health Information Technology (ONC), issued a request for information (RFI) seeking public input on improving the nation’s digital health infrastructure. The initiative aims to expand access to health technologies for Medicare beneficiaries by promoting interoperability, reducing administrative burdens, and enhancing patient-centered care. CMS is particularly focused on enabling the secure exchange of health data and encouraging the development of digital tools for health management. The public is invited to submit comments through June 16. Read the press release here.


HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers

On Tuesday, the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) issued a Request for Information (RFI) aimed at identifying outdated or unnecessary health care regulations. This initiative supports President Trump’s Executive Order “Unleashing Prosperity Through Deregulation” and includes a "10-to-1" policy requiring the elimination of at least ten existing regulations for every new one introduced. The effort seeks to reduce regulatory costs, eliminate administrative burdens, and allow providers to focus more on patient care. Comments will be open for 60 days until July 12, 2025. Read the press release here.


CMS Releases Draft Guidance for the Next Cycle of Medicare Drug Price Negotiations

On Monday, the Centers for Medicare & Medicaid Services (CMS) released draft guidance and asked for public input from a broad range of interested parties regarding the implementation of the Negotiation Program for initial price applicability year 2028 and manufacturer effectuation of the maximum fair prices in 2026, 2027, and 2028. The draft includes policies that seek to improve the transparency of the negotiation program and provide new information on how drugs payable under Part B will be included in the negotiation program for the first time and how to facilitate access to those negotiated drug prices. Notably, the document states that CMS believes it’s “generally appropriate” to treat combinations of active ingredients as a single entity for the purpose of identifying drugs that qualify for the program, endorsing the Biden administration’s approach to treating multiple insulins and GLP-1 products as a single drug subject to negotiations. The comment period is open until June 26, 2025. Read the draft guidance here.


Trump Administration Cancels Layoffs for Some HHS Employees

On Tuesday, the Trump administration notified some of the thousands of recently fired public health workers that their reduction-in-force notices are “hereby revoked.” The notice reinstates employees at the National Institute for Occupational Safety and Health (NIOSH), a Centers for Disease Control and Prevention (CDC) office that lost more than 90% of its workforce as part of HHS’s broader reduction-in-force last month. Employees who received the emails work for NIOSH teams that include the Respiratory Health Division, the Division of Safety Research, the Division of Compensation and Analysis Support, the National Personal Protective Technology Laboratory, and part of the Division of Field Studies and Surveillance. The offices conduct research and provide services to workers in high-risk fields like firefighting and coal mining. An HHS spokesperson declined to specify how many employees received similar notices, saying in a statement that the workers were rehired because the administration “remains committed to supporting coal miners, who play a vital role in America’s energy sector” and recognizes “the courage and selflessness of firefighters, who embody the principle that public service is the highest calling.”

CONGRESSIONAL HEARINGS & EVENTS

House:


House Committee on Oversight and Government Reform Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs – Hearing

“Mandates, Meddling, and Mismanagement: The IRA’s Threat to Energy and Medicine”

Tuesday, May 20, at 10:00 AM


Senate:


Senate Appropriations Committee, Subcommittee on Departments of Labor, Health and Human Services, and Education, and Related Agencies – Hearing

“To examine proposed budget estimates for fiscal year 2026 for the Department of Health and Human Services.”

Tuesday, May 20, at 10:00 AM

 

Senate Homeland Security and Governmental Affairs, Subcommittee on Investigations - Hearing

“To examine science and Federal health agencies, focusing on Myocarditis and other events associated with the COVID-19 vaccines.”

Wednesday, May 21, at 2:00 PM

 

Senate Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies – Hearing

“To examine proposed budget estimates for fiscal year 2026 for the Food and Drug Administration.”

Thursday, May 22, at 10:30 AM

ADMINISTRATION ANNOUNCEMENTS

Centers for Medicare & Medicaid Services

Food and Drug Administration

National Institutes of Health

1341 G Street NW
Washington, DC 20005
202-585-0258